↓ Skip to main content

Cochrane Database of Systematic Reviews

Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension

Overview of attention for article published in Cochrane database of systematic reviews, June 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs
1 blog
twitter
10 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
65 Mendeley
Title
Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension
Published in
Cochrane database of systematic reviews, June 2022
DOI 10.1002/14651858.cd013817.pub2
Pubmed ID
Authors

Josefine Clement Freiberg, Alexander von Spreckelsen, Miriam Kolko, Augusto Azuara-Blanco, Gianni Virgili

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 6%
Researcher 4 6%
Student > Bachelor 4 6%
Student > Master 4 6%
Student > Doctoral Student 2 3%
Other 6 9%
Unknown 41 63%
Readers by discipline Count As %
Medicine and Dentistry 8 12%
Nursing and Health Professions 6 9%
Biochemistry, Genetics and Molecular Biology 2 3%
Agricultural and Biological Sciences 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 4 6%
Unknown 42 65%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2023.
All research outputs
#2,259,941
of 26,183,699 outputs
Outputs from Cochrane database of systematic reviews
#4,536
of 13,191 outputs
Outputs of similar age
#49,272
of 451,894 outputs
Outputs of similar age from Cochrane database of systematic reviews
#68
of 123 outputs
Altmetric has tracked 26,183,699 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,191 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.5. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 451,894 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.